Abstract

Background: Both pre-sensitization to human leukocyte antigen and delayed graft function (DGF) is well documented to be asso ciated with poor allograft outcome. The aim of this study is to investigate whether development of DGF and pre-transplant highly sensitization has synergistic adverse effect on the allograft outcome after deceased donor kidney transplantation (DDKT) using Korean Transplant Registry (KOTRY) database, the nationwide prospective cohort. Methods: Between May 2014 and June 2019, total 1,945 DDKT were registered in KOTRY database and out of them, 1,370 cases were included in this study. According to pre-sensitization status and development of DGF post-transplant, they were divided into four groups: non-pre-sensitized-DGF(-) (n=1,100), non-pre-sensitized-DGF(+) (n=133), pre-sensitized-DGF(-) (n=116), and pre-sen sitized-DGF(+) (n=21). We compared allograft rejection, the change of allograft function, allograft survival, patient survival, and post-transplant complications across four groups. Results: The incidence of overall biopsy-proven rejection and acute antibody-mediated rejection (ABMR) was significantly higher in the pre-sensitized-DGF(+) group than the other three groups. In addition, multivariable analysis demonstrated that pre-sensi tization combined with DGF is an independent risk factor for both overall rejection and ABMR compared to non-pre-sensitized- DGF(-) group (hazard ratio, 10.769; 95% confidence interval, 3.717-31.198; P<0.001). Moreover, DGF and pre-sensitization showed statistically significant interaction each other (P for interaction <0.001). Pre-sensitization combined with DGF did not show a significant impact on allograft function and allograft or patient survival in this study. Conclusions: In conclusion, pre-sensitization and DGF show a synergistic adverse impact on the post-transplant allograft out come in terms of allograft rejection after DDKT. Therefore, we suggest when DGF occurred in DDKT with pre-sensitization, more careful monitoring or surveillance for allograft rejection is required.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call